Advertise X LinkedIn
Dow Jones 51,670.10 ▼0.35%S&P 500 7,805.45 ▼0.02%Nasdaq 27,204.38 ▼0.15%Russell 2000 2,783.37 ▼0.40%S&P/TSX 35,983.98 ▲0.90%Bovespa 206,887.52 ▼1.04%DAX 25,259.90 ▼0.07%FTSE 100 10,650.33 ▼0.06%CAC 40 7,827.63 ▼0.07%Euro Stoxx 50 6,167.01 ▼0.55%IBEX 35 19,210.70 ▼0.39%FTSE MIB 50,057.18 ▲0.04%Nikkei 225 67,777.52 ▼1.82%Shanghai 3,800.86 ▲0.10%Hang Seng 24,345.22 ▲0.30%KOSPI 6,035.35 ▼5.46%Nifty 50 22,721.95 ▲1.60%ASX 200 8,783.90 ▲0.00%AAPL 341.27 ▲0.09%NVDA 228.52 ▲0.97%MSFT 543.45 ▲0.43%GOOGL 353.78 ▲0.30%AMZN 258.58 ▼0.37%META 762.50 ▲2.63%TSLA 375.23 ▼0.74%JPM 331.43 ▼0.86%BTC 83,117.00 ▲0.15%ETH 2,504.62 ▼0.67%SOL 107.14 ▼1.20%EUR/USD 1.1197 ▲0.40%USD/INR 95.28 ▼0.51%GOLD 4,181.00 ▼0.23%CRUDE 95.06 ▲1.41%

analyst ratings

Stocks ·
WestPark Capital Initiates Akebia Therapeutics Coverage With Buy Rating

WestPark Capital initiates coverage of Akebia Therapeutics (AKBA) with a Buy rating on Sept. 8, 2026. Stock context, analyst targets, and consensus b…

Financial analyst workspace with stock chart on monitor and analyst report documents
Stocks ·
TechnipFMC Shares Cross Average Analyst Target: What the Ratings Signal

TechnipFMC (FTI) shares crossed the average analyst target of $12.14. Here's what the rating breakdown and price targets signal for investors.

Offshore oil and gas platform at sea representing TechnipFMC's subsea engineering business